Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease

27/08/2023
  • icon
  • icon
  • icon
REVIEW
published: 12 January 2022
doi: 10.3389/fcell.2021.742088

Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease

Yueyao Wang1,2† | Zhongwen Qi 3† | Zhipeng Yan1 | Nan Ji 1 | Xiaoya Yang1 | Dongjie Gao1 | Leilei Hu1 | Hao Lv 1 | Junping Zhang1* | Meng Li 1

3. The potential of MSCs in treating cardiovascular diseases
  • icon
  • icon
  • icon

Related articles

27/08/2023

12. MSCs in supporting organ transplantation

Paracrine Action Enhances the Effects of Autologous Mesenchymal Stem Cell Transplantation on Vascular Regeneration in Rat Model of Myocardial Infarction

View details

26/08/2023

1. The potential of MSCs in treating knee osteoarthritis

Mesenchymal stem cells in osteoarthritis therapy: a review

View details

11/10/2025

International Scientific Reports

5. Plasmapheresis in sepsis

View details

26/08/2023

7. Exosome therapy for respiratory disease

Exosomes from Endothelial Progenitor Cells Improve Outcomes of the Lipopolysaccharide-Induced Acute Lung Injury

View details

26/08/2023

7. Exosome therapy for respiratory disease

Pulmonary Delivery of siRNA Against Acute Lung Injury/Acute Respiratory Distress Syndrome

View details

27/08/2023

5. MSCs - a new therapy for chronic kidney disease

Adipose tissue-derived mesenchymal stromal cells for treating chronic kidney disease: A pilot study assessing safety and clinical feasibility

View details